_id

695fb636c2e91020a7bd41fe

Ticker

0HD2.LSE

Name

Alnylam Pharmaceuticals, Inc.

Exchange

LSE

Address

675 West Kendall Street, Cambridge, MA, United States, 02142

Country

UK

Sector

Industry

Currency

USD

Website

https://www.alnylam.com

Description

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Last Close

410.1598

Volume

-

Current Price

420.8653

Last Updated

2026-01-08T13:50:46.718Z

Ipo Date

-

Market Cap

4556138086400

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2025-09-30

Revenue

1249026000

Cost Of Revenue

197231000

Gross Profit

1051795000

Operating Expenses

683813000

Operating Income

367982000

Interest Expense

44398000

Pretax Income

238969000

Net Income

251084000

Eps

1.8280863208783529

Dividends Per Share

-

Shares Outstanding

101030000

Income Tax Expense

-12115000

EBITDA

297170000

Operating Margin

29.461516413589468

Total Other Income Expense Net

-129013000

Cash

1490249000

Short Term Investments

1234375000

Receivables

964768000

Inventories

75383000

Total Current Assets

3952811000

Property Plant Equipment

693144000

Total Assets

4851662000

Payables

117591000

Short Term Debt

160446000

Long Term Debt

-

Total Liabilities

4617768000

Equity

233894000

Bs_currency_symbol

-

Depreciation

13803000

Change In Working Capital

-204660000

Cash From Operations

325109000

Capital Expenditures

12142000

Cash From Investing

501107000

Cash From Financing

-448348000

Net Change In Cash

376941000

Cf_currency_symbol

-

PE

-

PB

247.1418985711476

ROE

107.34948309918168

ROA

5.1752162454845365

FCF

312967000

Fcf Percent

0.25056884324265466

Piotroski FScore

4

Health Score

64

Deep Value Investing Score

6

Defensive Investing Score

5.5

Dividend Investing Score

3

Economic Moat Investing Score

8

Garp Investing Score

6

Growth Investing Score

6

Momentum Investing Score

3

Net Net Investing Score

3

Quality Investing Score

9

Value Investing Score

7

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

1249026000

Quarters > 0 > income Statement > cost Of Revenue

197231000

Quarters > 0 > income Statement > gross Profit

1051795000

Quarters > 0 > income Statement > operating Expenses

683813000

Quarters > 0 > income Statement > operating Income

367982000

Quarters > 0 > income Statement > interest Expense

44398000

Quarters > 0 > income Statement > pretax Income

238969000

Quarters > 0 > income Statement > net Income

251084000

Quarters > 0 > income Statement > eps

1.8280863208783529

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

137348000

Quarters > 0 > income Statement > income Tax Expense

-12115000

Quarters > 0 > income Statement > EBITDA

297170000

Quarters > 0 > income Statement > operating Margin

29.461516413589468

Quarters > 0 > income Statement > total Other Income Expense Net

-129013000

Quarters > 0 > income Statement > currency_symbol

-

Quarters > 0 > balance Sheet > cash

1490249000

Quarters > 0 > balance Sheet > short Term Investments

1234375000

Quarters > 0 > balance Sheet > receivables

964768000

Quarters > 0 > balance Sheet > inventories

75383000

Quarters > 0 > balance Sheet > total Current Assets

3952811000

Quarters > 0 > balance Sheet > property Plant Equipment

693144000

Quarters > 0 > balance Sheet > total Assets

4851662000

Quarters > 0 > balance Sheet > payables

117591000

Quarters > 0 > balance Sheet > short Term Debt

160446000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

4617768000

Quarters > 0 > balance Sheet > equity

233894000

Quarters > 0 > balance Sheet > currency_symbol

-

Quarters > 0 > cash Flow > net Income

251084000

Quarters > 0 > cash Flow > depreciation

13803000

Quarters > 0 > cash Flow > change In Working Capital

-204660000

Quarters > 0 > cash Flow > cash From Operations

325109000

Quarters > 0 > cash Flow > capital Expenditures

12142000

Quarters > 0 > cash Flow > cash From Investing

501107000

Quarters > 0 > cash Flow > cash From Financing

-448348000

Quarters > 0 > cash Flow > net Change In Cash

376941000

Quarters > 0 > cash Flow > currency_symbol

-

Quarters > 0 > ratios > PE

1.8280863208783529

Quarters > 0 > ratios > PB

247.1418985711476

Quarters > 0 > ratios > ROE

107.34948309918168

Quarters > 0 > ratios > ROA

5.1752162454845365

Quarters > 0 > ratios > FCF

312967000

Quarters > 0 > ratios > Piotroski FScore

4

Quarters > 0 > ratios > fcf Percent

0.25056884324265466

Quarters > 0 > health Score

64

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

773689000

Quarters > 1 > income Statement > cost Of Revenue

142953000

Quarters > 1 > income Statement > gross Profit

630736000

Quarters > 1 > income Statement > operating Expenses

646935000

Quarters > 1 > income Statement > operating Income

-16199000

Quarters > 1 > income Statement > interest Expense

40246000

Quarters > 1 > income Statement > pretax Income

-35358000

Quarters > 1 > income Statement > net Income

-66277000

Quarters > 1 > income Statement > eps

-0.5073720833770101

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

130627999

Quarters > 1 > income Statement > income Tax Expense

30919000

Quarters > 1 > income Statement > EBITDA

18831999

Quarters > 1 > income Statement > operating Margin

-2.0937353381009682

Quarters > 1 > income Statement > total Other Income Expense Net

-19159000

Quarters > 1 > income Statement > currency_symbol

-

Quarters > 1 > balance Sheet > cash

1113685000

Quarters > 1 > balance Sheet > short Term Investments

1743900000

Quarters > 1 > balance Sheet > receivables

567112000

Quarters > 1 > balance Sheet > inventories

71688000

Quarters > 1 > balance Sheet > total Current Assets

3643699000

Quarters > 1 > balance Sheet > property Plant Equipment

692192000

Quarters > 1 > balance Sheet > total Assets

4566019000

Quarters > 1 > balance Sheet > payables

102393000

Quarters > 1 > balance Sheet > short Term Debt

143620000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

4315428000

Quarters > 1 > balance Sheet > equity

250591000

Quarters > 1 > balance Sheet > currency_symbol

-

Quarters > 1 > cash Flow > net Income

-66277000

Quarters > 1 > cash Flow > depreciation

13944000

Quarters > 1 > cash Flow > change In Working Capital

50077000

Quarters > 1 > cash Flow > cash From Operations

153730000

Quarters > 1 > cash Flow > capital Expenditures

14293000

Quarters > 1 > cash Flow > cash From Investing

-141381000

Quarters > 1 > cash Flow > cash From Financing

53757000

Quarters > 1 > cash Flow > net Change In Cash

94031000

Quarters > 1 > cash Flow > currency_symbol

USD

Quarters > 1 > ratios > PE

-0.5073720833770101

Quarters > 1 > ratios > PB

219.38853345704635

Quarters > 1 > ratios > ROE

-26.44827627488617

Quarters > 1 > ratios > ROA

-1.4515270304394265

Quarters > 1 > ratios > FCF

139437000

Quarters > 1 > ratios > Piotroski FScore

2

Quarters > 1 > ratios > fcf Percent

0.18022357820778118

Quarters > 1 > health Score

26

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

594189000

Quarters > 2 > income Statement > cost Of Revenue

71041000

Quarters > 2 > income Statement > gross Profit

523148000

Quarters > 2 > income Statement > operating Expenses

505071000

Quarters > 2 > income Statement > operating Income

18077000

Quarters > 2 > income Statement > interest Expense

38646000

Quarters > 2 > income Statement > pretax Income

-41596000

Quarters > 2 > income Statement > net Income

-57479000

Quarters > 2 > income Statement > eps

-0.44325087482071374

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

129675999

Quarters > 2 > income Statement > income Tax Expense

15883000

Quarters > 2 > income Statement > EBITDA

32482000

Quarters > 2 > income Statement > operating Margin

3.042297989360288

Quarters > 2 > income Statement > total Other Income Expense Net

-59673000

Quarters > 2 > income Statement > currency_symbol

-

Quarters > 2 > balance Sheet > cash

1019654000

Quarters > 2 > balance Sheet > short Term Investments

1612568000

Quarters > 2 > balance Sheet > receivables

418035000

Quarters > 2 > balance Sheet > inventories

65581000

Quarters > 2 > balance Sheet > total Current Assets

3268258000

Quarters > 2 > balance Sheet > property Plant Equipment

695917000

Quarters > 2 > balance Sheet > total Assets

4213810999

Quarters > 2 > balance Sheet > payables

97399000

Quarters > 2 > balance Sheet > short Term Debt

127804000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

4098375999

Quarters > 2 > balance Sheet > equity

115435000

Quarters > 2 > balance Sheet > currency_symbol

-

Quarters > 2 > cash Flow > net Income

-57479000

Quarters > 2 > cash Flow > depreciation

14405000

Quarters > 2 > cash Flow > change In Working Capital

-33988000

Quarters > 2 > cash Flow > cash From Operations

-118314000

Quarters > 2 > cash Flow > capital Expenditures

8970000

Quarters > 2 > cash Flow > cash From Investing

113769000

Quarters > 2 > cash Flow > cash From Financing

44084000

Quarters > 2 > cash Flow > net Change In Cash

53597000

Quarters > 2 > cash Flow > currency_symbol

USD

Quarters > 2 > ratios > PE

-0.44325087482071374

Quarters > 2 > ratios > PB

472.78666108142846

Quarters > 2 > ratios > ROE

-49.793390219604106

Quarters > 2 > ratios > ROA

-1.3640621284068182

Quarters > 2 > ratios > FCF

-127284000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-0.21421466906994238

Quarters > 2 > health Score

8

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

593166000

Quarters > 3 > income Statement > cost Of Revenue

102817000

Quarters > 3 > income Statement > gross Profit

490349000

Quarters > 3 > income Statement > operating Expenses

595508000

Quarters > 3 > income Statement > operating Income

-105159000

Quarters > 3 > income Statement > interest Expense

38971000

Quarters > 3 > income Statement > pretax Income

-193958000

Quarters > 3 > income Statement > net Income

-83763000

Quarters > 3 > income Statement > eps

-0.6487422163016202

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

129116000

Quarters > 3 > income Statement > income Tax Expense

-110195000

Quarters > 3 > income Statement > EBITDA

-140819000

Quarters > 3 > income Statement > operating Margin

-17.728426781036

Quarters > 3 > income Statement > total Other Income Expense Net

-88799000

Quarters > 3 > income Statement > currency_symbol

-

Quarters > 3 > balance Sheet > cash

966428000

Quarters > 3 > balance Sheet > short Term Investments

1728076000

Quarters > 3 > balance Sheet > receivables

405308000

Quarters > 3 > balance Sheet > inventories

78509000

Quarters > 3 > balance Sheet > total Current Assets

3295285000

Quarters > 3 > balance Sheet > property Plant Equipment

693932000

Quarters > 3 > balance Sheet > total Assets

4301817000

Quarters > 3 > balance Sheet > payables

88415000

Quarters > 3 > balance Sheet > short Term Debt

154904000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

4234729000

Quarters > 3 > balance Sheet > equity

67088000

Quarters > 3 > balance Sheet > currency_symbol

-

Quarters > 3 > cash Flow > net Income

-83763000

Quarters > 3 > cash Flow > depreciation

14168000

Quarters > 3 > cash Flow > change In Working Capital

-74212000

Quarters > 3 > cash Flow > cash From Operations

-94662000

Quarters > 3 > cash Flow > capital Expenditures

9094000

Quarters > 3 > cash Flow > cash From Investing

-52910000

Quarters > 3 > cash Flow > cash From Financing

30997000

Quarters > 3 > cash Flow > net Change In Cash

-133492000

Quarters > 3 > cash Flow > currency_symbol

USD

Quarters > 3 > ratios > PE

-0.6487422163016202

Quarters > 3 > ratios > PB

809.9875398700215

Quarters > 3 > ratios > ROE

-124.85541378487956

Quarters > 3 > ratios > ROA

-1.9471539584319835

Quarters > 3 > ratios > FCF

-103756000

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-0.1749189940084226

Quarters > 3 > health Score

8

Annuals > 0 > quarter

2024-12-31

Annuals > 0 > income Statement > revenue

2248243000

Annuals > 0 > income Statement > cost Of Revenue

323370000

Annuals > 0 > income Statement > gross Profit

1924873000

Annuals > 0 > income Statement > operating Expenses

2101758000

Annuals > 0 > income Statement > operating Income

-176885000

Annuals > 0 > income Statement > interest Expense

141858000

Annuals > 0 > income Statement > pretax Income

-377375000

Annuals > 0 > income Statement > net Income

-278157000

Annuals > 0 > income Statement > eps

-2.179042859045366

Annuals > 0 > income Statement > dividends Per Share

-

Annuals > 0 > income Statement > shares Outstanding

127651000

Annuals > 0 > income Statement > income Tax Expense

-99218000

Annuals > 0 > income Statement > EBITDA

-178847000

Annuals > 0 > income Statement > operating Margin

-7.867699354562651

Annuals > 0 > income Statement > total Other Income Expense Net

-200490000

Annuals > 0 > income Statement > currency_symbol

-

Annuals > 0 > balance Sheet > cash

966428000

Annuals > 0 > balance Sheet > short Term Investments

1728076000

Annuals > 0 > balance Sheet > receivables

405308000

Annuals > 0 > balance Sheet > inventories

78509000

Annuals > 0 > balance Sheet > total Current Assets

3295285000

Annuals > 0 > balance Sheet > property Plant Equipment

693932000

Annuals > 0 > balance Sheet > total Assets

4301817000

Annuals > 0 > balance Sheet > payables

88415000

Annuals > 0 > balance Sheet > short Term Debt

196790000

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

4234729000

Annuals > 0 > balance Sheet > equity

67088000

Annuals > 0 > balance Sheet > currency_symbol

-

Annuals > 0 > cash Flow > net Income

-278157000

Annuals > 0 > cash Flow > depreciation

56670000

Annuals > 0 > cash Flow > change In Working Capital

-214084000

Annuals > 0 > cash Flow > cash From Operations

-8312000

Annuals > 0 > cash Flow > capital Expenditures

34277000

Annuals > 0 > cash Flow > cash From Investing

-116840000

Annuals > 0 > cash Flow > cash From Financing

294159000

Annuals > 0 > cash Flow > net Change In Cash

153768000

Annuals > 0 > cash Flow > currency_symbol

-

Annuals > 0 > ratios > PE

-2.179042859045366

Annuals > 0 > ratios > PB

800.7971084292273

Annuals > 0 > ratios > ROE

-414.6151323634629

Annuals > 0 > ratios > ROA

-6.466035166070523

Annuals > 0 > ratios > FCF

-42589000

Annuals > 0 > ratios > Piotroski FScore

1

Annuals > 0 > ratios > fcf Percent

-0.01894323700774338

Annuals > 0 > health Score

9

Annuals > 1 > quarter

2023-12-31

Annuals > 1 > income Statement > revenue

1828292000

Annuals > 1 > income Statement > cost Of Revenue

310406000

Annuals > 1 > income Statement > gross Profit

1517886000

Annuals > 1 > income Statement > operating Expenses

1800061000

Annuals > 1 > income Statement > operating Income

-282175000

Annuals > 1 > income Statement > interest Expense

121221000

Annuals > 1 > income Statement > pretax Income

-433517000

Annuals > 1 > income Statement > net Income

-440242000

Annuals > 1 > income Statement > eps

-3.524586489039758

Annuals > 1 > income Statement > dividends Per Share

-

Annuals > 1 > income Statement > shares Outstanding

124906000

Annuals > 1 > income Statement > income Tax Expense

6725000

Annuals > 1 > income Statement > EBITDA

-228121000

Annuals > 1 > income Statement > operating Margin

-15.433803790641756

Annuals > 1 > income Statement > total Other Income Expense Net

-151342000

Annuals > 1 > income Statement > currency_symbol

-

Annuals > 1 > balance Sheet > cash

812688000

Annuals > 1 > balance Sheet > short Term Investments

1626694000

Annuals > 1 > balance Sheet > receivables

327787000

Annuals > 1 > balance Sheet > inventories

89146000

Annuals > 1 > balance Sheet > total Current Assets

2982697000

Annuals > 1 > balance Sheet > property Plant Equipment

725789000

Annuals > 1 > balance Sheet > total Assets

3829880000

Annuals > 1 > balance Sheet > payables

55519000

Annuals > 1 > balance Sheet > short Term Debt

96501000

Annuals > 1 > balance Sheet > long Term Debt

-

Annuals > 1 > balance Sheet > total Liabilities

4050524000

Annuals > 1 > balance Sheet > equity

-220644000

Annuals > 1 > balance Sheet > currency_symbol

-

Annuals > 1 > cash Flow > net Income

-440242000

Annuals > 1 > cash Flow > depreciation

97031000

Annuals > 1 > cash Flow > change In Working Capital

-125103000

Annuals > 1 > cash Flow > cash From Operations

104156000

Annuals > 1 > cash Flow > capital Expenditures

62211000

Annuals > 1 > cash Flow > cash From Investing

-336350000

Annuals > 1 > cash Flow > cash From Financing

172131000

Annuals > 1 > cash Flow > net Change In Cash

-53672000

Annuals > 1 > cash Flow > currency_symbol

USD

Annuals > 1 > ratios > PE

-3.524586489039758

Annuals > 1 > ratios > PB

-238.25076214082412

Annuals > 1 > ratios > ROE

199.52593317742608

Annuals > 1 > ratios > ROA

-11.494929345044753

Annuals > 1 > ratios > FCF

41945000

Annuals > 1 > ratios > Piotroski FScore

2

Annuals > 1 > ratios > fcf Percent

0.022942177726533838

Annuals > 1 > health Score

32

Annuals > 2 > quarter

2022-12-31

Annuals > 2 > income Statement > revenue

1037418000

Annuals > 2 > income Statement > cost Of Revenue

168817000

Annuals > 2 > income Statement > gross Profit

868601000

Annuals > 2 > income Statement > operating Expenses

1653673000

Annuals > 2 > income Statement > operating Income

-785072000

Annuals > 2 > income Statement > interest Expense

155968000

Annuals > 2 > income Statement > pretax Income

-1126993000

Annuals > 2 > income Statement > net Income

-1131156000

Annuals > 2 > income Statement > eps

-9.295466311663338

Annuals > 2 > income Statement > dividends Per Share

-

Annuals > 2 > income Statement > shares Outstanding

121689000

Annuals > 2 > income Statement > income Tax Expense

4163000

Annuals > 2 > income Statement > EBITDA

-740604000

Annuals > 2 > income Statement > operating Margin

-75.67557146685328

Annuals > 2 > income Statement > total Other Income Expense Net

-341921000

Annuals > 2 > income Statement > currency_symbol

-

Annuals > 2 > balance Sheet > cash

866394000

Annuals > 2 > balance Sheet > short Term Investments

1326012000

Annuals > 2 > balance Sheet > receivables

237963000

Annuals > 2 > balance Sheet > inventories

128962000

Annuals > 2 > balance Sheet > total Current Assets

2692247000

Annuals > 2 > balance Sheet > property Plant Equipment

738630000

Annuals > 2 > balance Sheet > total Assets

3546359000

Annuals > 2 > balance Sheet > payables

98094000

Annuals > 2 > balance Sheet > short Term Debt

82256000

Annuals > 2 > balance Sheet > long Term Debt

-

Annuals > 2 > balance Sheet > total Liabilities

3704582000

Annuals > 2 > balance Sheet > equity

-158223000

Annuals > 2 > balance Sheet > currency_symbol

-

Annuals > 2 > cash Flow > net Income

-1131156000

Annuals > 2 > cash Flow > depreciation

44468000

Annuals > 2 > cash Flow > change In Working Capital

-35553000

Annuals > 2 > cash Flow > cash From Operations

-541274000

Annuals > 2 > cash Flow > capital Expenditures

72059000

Annuals > 2 > cash Flow > cash From Investing

169354000

Annuals > 2 > cash Flow > cash From Financing

425753000

Annuals > 2 > cash Flow > net Change In Cash

44241000

Annuals > 2 > cash Flow > currency_symbol

USD

Annuals > 2 > ratios > PE

-9.295466311663338

Annuals > 2 > ratios > PB

-323.6866795074041

Annuals > 2 > ratios > ROE

714.9124969189056

Annuals > 2 > ratios > ROA

-31.896263181477114

Annuals > 2 > ratios > FCF

-613333000

Annuals > 2 > ratios > Piotroski FScore

1

Annuals > 2 > ratios > fcf Percent

-0.5912110643925592

Annuals > 2 > health Score

31

Annuals > 3 > quarter

2021-12-31

Annuals > 3 > income Statement > revenue

844287000

Annuals > 3 > income Statement > cost Of Revenue

140144000

Annuals > 3 > income Statement > gross Profit

704143000

Annuals > 3 > income Statement > operating Expenses

1412795000

Annuals > 3 > income Statement > operating Income

-708652000

Annuals > 3 > income Statement > interest Expense

143021000

Annuals > 3 > income Statement > pretax Income

-852144000

Annuals > 3 > income Statement > net Income

-852824000

Annuals > 3 > income Statement > eps

-7.199804138420106

Annuals > 3 > income Statement > dividends Per Share

-

Annuals > 3 > income Statement > shares Outstanding

118451000

Annuals > 3 > income Statement > income Tax Expense

680000

Annuals > 3 > income Statement > EBITDA

-661085000

Annuals > 3 > income Statement > operating Margin

-83.93496524286172

Annuals > 3 > income Statement > total Other Income Expense Net

-143492000

Annuals > 3 > income Statement > currency_symbol

-

Annuals > 3 > balance Sheet > cash

822153000

Annuals > 3 > balance Sheet > short Term Investments

1615589000

Annuals > 3 > balance Sheet > receivables

198571000

Annuals > 3 > balance Sheet > inventories

86363000

Annuals > 3 > balance Sheet > total Current Assets

2808576000

Annuals > 3 > balance Sheet > property Plant Equipment

733633000

Annuals > 3 > balance Sheet > total Assets

3643304000

Annuals > 3 > balance Sheet > payables

73426000

Annuals > 3 > balance Sheet > short Term Debt

77627000

Annuals > 3 > balance Sheet > long Term Debt

-

Annuals > 3 > balance Sheet > total Liabilities

3055101000

Annuals > 3 > balance Sheet > equity

588203000

Annuals > 3 > balance Sheet > currency_symbol

-

Annuals > 3 > cash Flow > net Income

-852824000

Annuals > 3 > cash Flow > depreciation

89694000

Annuals > 3 > cash Flow > change In Working Capital

-162823000

Annuals > 3 > cash Flow > cash From Operations

-641693000

Annuals > 3 > cash Flow > capital Expenditures

76372000

Annuals > 3 > cash Flow > cash From Investing

-273300000

Annuals > 3 > cash Flow > cash From Financing

1247118000

Annuals > 3 > cash Flow > net Change In Cash

323107000

Annuals > 3 > cash Flow > currency_symbol

USD

Annuals > 3 > ratios > PE

-7.199804138420106

Annuals > 3 > ratios > PB

84.75290954024376

Annuals > 3 > ratios > ROE

-144.98803984338738

Annuals > 3 > ratios > ROA

-23.407983522648674

Annuals > 3 > ratios > FCF

-718065000

Annuals > 3 > ratios > Piotroski FScore

0

Annuals > 3 > ratios > fcf Percent

-0.8504987048243073

Annuals > 3 > health Score

8

Valuation > metrics > PE

1.8280863208783529

Valuation > metrics > PB

247.1418985711476

Valuation > final Score

40

Valuation > verdict

4028.2% Overvalued

Profitability > metrics > ROE

107.34948309918168

Profitability > metrics > ROA

6.352036563346945

Profitability > metrics > Net Margin

0.2010238377743938

Profitability > final Score

89

Profitability > verdict

Adequate

Risk > metrics > Debt Equity

19.742994689902265

Risk > metrics > Interest Coverage

8.288256227758007

Risk > final Score

39

Risk > verdict

High

Liquidity > metrics > Current Ratio

14.216852433309235

Liquidity > metrics > Quick Ratio

13.945726647892187

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

20

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

4

Prev Risks > 1

8

Prev Risks > 2

-5

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T23:13:28.332Z

Earnings History > 0 > period

2025-12-31

Earnings History > 0 > report Date

2026-02-12

Earnings History > 0 > date

2025-12-31

Earnings History > 0 > before After Market

BeforeMarket

Earnings History > 0 > currency

-

Earnings History > 0 > eps Actual

-

Earnings History > 0 > eps Estimate

1.73

Earnings History > 0 > eps Difference

0

Earnings History > 0 > surprise Percent

-